Last updated on July 2019

Study to Evaluate the Real-world Effectiveness of Lanadelumab in Participants With Hereditary Angioedema (HAE)

Brief description of study

This observational, prospective study aims to evaluate the real-world effectiveness of lanadelumab in participants with hereditary angioedema (HAE). Participant-reported attack diaries and patient-reported outcomes (PROs) as well as physician assessments at standard of care (SoC) visits will be used to describe HAE attack rates, treatment patterns, healthcare utilization and participant quality of life.

Clinical Study Identifier: NCT03845400

Find a site near you

Start Over

Medical Research of Arizona

Scottsdale, AZ United States
  Connect »

AIRE Medical of Los Angeles

Santa Monica, CA United States
  Connect »

Asthma and Allergy Associates, PC

Colorado Springs, CO United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

Mid West Immunology Clinic

Plymouth, MN United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Allergy Consultants, P.A.

Verona, NJ United States
  Connect »

The Mount Sinai Hospital

New York, NY United States
  Connect »

Clinical Research of Charlotte

Charlotte, NC United States
  Connect »

AARA Research Center

Dallas, TX United States
  Connect »

CHUM H tel-Dieu

Montreal, QC Canada
  Connect »